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Clinics and pathology 
Disease 
Acute myeloid leukaemia (AML) 
Epidemiology 












Transcription factor (activator) for various  
hematopoietic-specific genes, which expression is 
limited to hematopoetic stem cells, and endothelial 
cells and mesenchymal cells in the embryo; core 
binding factor family member which forms 
heterodimers with CBFB; binds to the core site 5' 
PyGPyGGTPy 3' of promotors and enhancers. 




5' RUNX1- 3' YTHDF2 
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